Jamison Private Wealth Management Inc. Buys 146 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Jamison Private Wealth Management Inc. lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 11.9% in the 4th quarter, HoldingsChannel reports. The firm owned 1,371 shares of the healthcare conglomerate’s stock after buying an additional 146 shares during the quarter. Jamison Private Wealth Management Inc.’s holdings in UnitedHealth Group were worth $693,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. Kathleen S. Wright Associates Inc. bought a new stake in UnitedHealth Group in the 3rd quarter valued at about $27,000. Global Wealth Strategies & Associates boosted its holdings in UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after buying an additional 32 shares during the period. West Financial Advisors LLC bought a new stake in UnitedHealth Group during the 3rd quarter valued at $32,000. AlphaMark Advisors LLC bought a new position in shares of UnitedHealth Group in the fourth quarter worth $30,000. Finally, RPg Family Wealth Advisory LLC purchased a new stake in UnitedHealth Group during the 3rd quarter worth about $37,000. 87.86% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm’s stock in a transaction that occurred on Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now directly owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.33% of the company’s stock.

Analyst Upgrades and Downgrades

UNH has been the topic of a number of recent analyst reports. UBS Group lowered their price target on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target for the company in a research report on Friday, January 10th. Bank of America reduced their target price on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Piper Sandler dropped their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. Finally, Truist Financial lowered their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. One equities research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Buy” and an average target price of $627.74.

UnitedHealth Group Price Performance

UNH stock opened at $532.26 on Friday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm’s 50-day moving average price is $541.04 and its two-hundred day moving average price is $563.84. The stock has a market capitalization of $489.83 billion, a price-to-earnings ratio of 34.34, a PEG ratio of 1.41 and a beta of 0.62. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business’s revenue was up 6.8% on a year-over-year basis. During the same quarter last year, the business posted $5.83 EPS. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 29.74 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.58%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s payout ratio is currently 54.19%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.